Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-28

Clinical Trial Update: The Effect of Mobile Application on Subcutaneous Anti-TNF Drug Administration:Ankylosing Spondylitis Patients [NA]

View source ↗

Summary

A clinical trial investigating a mobile application to assist subcutaneous anti-TNF administration in ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unspecified subcutaneous anti-TNF therapy

Snippet

Sponsor: Eskisehir Osmangazi University | Conditions: Ankylosing Spondylitis, Spondylitis, Ankylosing | NA | Status: COMPLETED